Hereditary Colorectal Cancer for the Primary Care Physician
Release date: Februrary 19, 2021
Expiration date: February 19, 2024
Estimated Time of Completion: 1 hour
Description
Each lesson in the Disease Management Clinical Decisions series provides a brief, case-based review of management strategies related to the topic. Questions and multiple-choice answers about the case presented include the rationale for the correct answer. Throughout this case-based lesson, you may proceed to the next question once you answer the question correctly.
Disclosures
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
Anthony Fernandez, MD, PhD | ||
Abbvie Pharmaceuticals | Consulting; Membership on advisory committee or review panels; Teaching and Speaking | |
Celgene Corporation, UCB | Consulting | |
Corbus Pharmaceuticals | Research / Independent Contractor | |
Mallinckrodt Inc. | Consulting; Research / Independent Contractor; Teaching and Speaking | |
Novartis | Consulting; Research / Independent Contractor; Teaching and Speaking | |
Pfizer, Inc. | Research / Independent Contractor | |
Roche Pharmaceuticals | Principal Investigator for a Phase III Clinical Trial | |
UCB | Consulting |
The following faculty have indicated he has no relationship which, in the context of his presentation(s), could be perceived as a potential conflict of interest:
Gautam Mankaney, MD
This CME activity was produced by The Cleveland Clinic Foundation
Center for Continuing Education.